Daylla

Daylla is a combined oral contraceptive containing drospirenone and ethinylestradiol. It is used for birth control and may help manage acne and premenstrual symptoms. This medication is manufactured by Gedeon Richter Plc.

Daylla is primarily used for contraception, helping to prevent pregnancy by regulating hormone levels. It may also be prescribed to treat acne and alleviate symptoms of premenstrual dysphoric disorder (PMDD). The active ingredients, drospirenone and ethinylestradiol, work together to provide these benefits.

Common effects of Daylla may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience breast tenderness, headaches, or nausea. These effects vary and typically subside as the body adjusts to the medication.

Daylla should be used under medical supervision. It is important to inform your healthcare provider about any pre-existing conditions, especially those related to blood clots, liver disease, or hormone-sensitive conditions. Regular check-ups are recommended while using this medication.

Daylla may interact with certain medications, including those that induce or inhibit liver enzymes, such as some antibiotics and antifungal drugs. Alcohol and tobacco use may also affect the efficacy and safety of Daylla. Always consult a healthcare provider before starting or stopping any medication.